'''Menabitan''' ([[International Nonproprietary Name|INN]]; '''SP-204'''), or '''menabitan hydrochloride''' ([[United States Adopted Name|USAN]]), is a [[Chemical synthesis|synthetic]] [[drug]] which acts as a [[potency (pharmacology)|potent]] [[cannabinoid receptor]] [[agonist]].<ref name="pmid402656">{{cite journal | author = Green K, Kim K | title = Acute dose response of intraocular pressure to topical and oral cannabinoids | journal = Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) | volume = 154 | issue = 2 | pages = 228–31 |date=February 1977 | pmid = 402656 | doi = 10.3181/00379727-154-39643| url = }}</ref><ref name="isbn978-0-412-46630-4">{{cite book | author = David J. Triggle | title = Dictionary of Pharmacological Agents | publisher = Chapman & Hall/CRC | location = Boca Raton | year = 1996 | page = 1271 | isbn = 978-0-412-46630-4 | oclc = | doi = | url = https://books.google.com/books?id=A0THacd46ZsC&pg=PA1271}}</ref> It is closely related to [[natural product|natural]] [[cannabinoid]]s of the [[tetrahydrocannabinol]] (THC) group, differing mainly by its longer and branched [[side chain]], and the replacement of the 9-position carbon with a  nitrogen.<ref name="pmid402656" /> It was studied as an [[analgesic]] in the 1970s and was found to possess [[antinociceptive]] effects in both humans and animals but was never marketed.<ref name="pmid402656" /><ref name="pmid2830539">{{cite journal | author = Reggio PH | title = Molecular determinants for cannabinoid activity: refinement of a molecular reactivity template | journal = NIDA Research Monograph | volume = 79 | issue = | pages = 82–95 | year = 1987 | pmid = 2830539 | doi = | url = }}</ref><ref name="Nahas1999">{{cite book | author = Gabriel G. Nahas | title = Marihuana and Medicine | url = https://books.google.com/books?id=eWrbKBQ5j7gC&pg=PA46 | accessdate = 9 May 2012 | date = 5 April 1999 | publisher = Humana Press | isbn = 978-0-89603-593-5 | page = 46}}</ref>
